Inventor
Shari Lynn CAPLAN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
C07HSugars7%
C12NMicroorganisms or enzymes7%
PatentTitleYear
12,527,841Fibroblast growth factor-21-Fc fusion proteins202611,944,664Fibroblast growth factor-21-Fc fusion proteins202411,802,152Methods of treating FGF21-associated disorders202311,377,656Chemically modified messenger RNA's202211,236,159Methods of treating FGF21-associated disorders2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to NOVARTIS AG (5)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 5 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2026 |